Knight Therapeutics's market cap is currently ―. The company's EPS TTM is $-0.122; its P/E ratio is -34.68; Knight Therapeutics is scheduled to report earnings on May 9, 2024, and the estimated EPS forecast is

lt;0.01. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22
Income Statement	-
Total Revenue	C$ 74.20M	C$ 81.50M	C$ 89.91M	C$ 82.60M	C$ 81.66M
Gross Profit	C$ 34.22M	C$ 40.18M	C$ 37.49M	C$ 40.76M	C$ 36.89M
EBIT	C$ -22.06M	C$ 11.50M	C$ 3.22M	C$ -2.15M	C$ -25.11M
EBITDA	C$ -10.60M	C$ 25.20M	C$ 15.37M	C$ 10.93M	-
Net Income Common Stockholders	C$ -24.33M	C$ 9.59M	C$ 1.84M	C$ -3.94M	C$ -15.19M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	C$ 154.42M	C$ 142.46M	C$ 130.50M	C$ 145.31M	C$ 157.50M
Total Assets	C$ 945.49M	C$ 1.01B	C$ 1.01B	C$ 1.04B	C$ 1.05B
Total Debt	C$ 69.09M	C$ 82.24M	C$ 79.20M	C$ 82.64M	C$ 77.70M
Net Debt	C$ -85.33M	C$ -60.22M	C$ -51.30M	C$ -62.67M	C$ -79.81M
Total Liabilities	C$ 198.62M	C$ 196.48M	C$ 206.54M	C$ 225.91M	C$ 228.98M
Stockholders Equity	C$ 746.87M	C$ 814.66M	C$ 807.20M	C$ 818.87M	C$ 825.86M
Cash Flow	-
Free Cash Flow	C$ 18.75M	C$ 14.88M	C$ -1.64M	C$ -4.08M	C$ 2.21M
Operating Cash Flow	C$ 18.55M	C$ 15.17M	C$ -1.49M	C$ 3.71M	C$ 8.87M
Investing Cash Flow	C$ -1.90M	C$ 35.76M	C$ 4.20M	C$ -8.71M	C$ -65.02M
Financing Cash Flow	C$ -36.40M	C$ -11.24M	C$ -22.09M	C$ -11.27M	C$ 29.86M

Currency in CAD

Knight Therapeutics Earnings and Revenue History

Income Statement >

Knight Therapeutics Debt to Assets

Balance Sheet >

Knight Therapeutics Cash Flow

Cash Flow >

Knight Therapeutics Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing